+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder



Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder



Hinyokika Kiyo. Acta Urologica Japonica 32(11): 1663-1676



The significance of Thomsen-Friedenreich antigen (T-Ag) in bladder carcinomas and multiple mucosal biopsies was studied. The T-antigen, a precursor of MN blood group antigen, is not found in normal cells, in which T-antigen is cryptic (cryptic T-Ag) but can be unmasked with neuraminidase digestion. Specimens of 27 main tumors and 201 mucosal biopsies from 28 patients with carcinoma in situ or microinvasion of carcinoma in situ were examined for the expression of T-antigen by Avidin-Biotin-Peroxidase Complex (ABC) method with peanut agglutinin (PNA). The T-Ag-positive rate was 22% for G2 tumors, 56% for G3 tumors, while cryptic T-Ag-positive rate was 86% for G2 tumors and 50% for G3 tumors. The correlation between T-antigen, cryptic T-antigen and histologic grade was not statistically significant. The T-Ag-positive rate in mucosal biopsies was 43% in microinvasion of carcinoma in situ, 11% in carcinoma in situ, 17% in transitional cell carcinoma, 8% in dysplasia, 33% in squamous metaplasia, 33% in proliferative cystitis and 13% in normal epithelium. Of histological findings, microinvasion of carcinoma in situ showed a significantly higher T-Ag-positive rate than carcinoma in situ and normal epithelium (P less than 0.005, P less than 0.001). The cryptic T-Ag-positive rate in mucosal biopsies was 38% in microinvasion of carcinoma in situ, 74% in carcinoma in situ, 100% in transitional cell carcinoma, 82% in dysplasia, 100% in squamous metaplasia, 100% in proliferative cystitis and 96% in normal epithelium. Of the histological findings, carcinoma in situ, proliferactive cystitis and normal epithelium showed a significantly higher cryptic T-Ag-positive rate than microinvasion of carcinoma in situ (P less than 0.025, P less than 0.05, P less than 0.001). Microinvasion of carcinoma in situ expressed the T-Ag (43%), the cryptic T-Ag (21%) and lacked the cryptic T-Ag (36%). Microinvasion of carcinoma in situ showed statistically significant difference in the mode of T-Ag and cryptic T-Ag expression than other histological types in mucosal biopsies, including carcinoma in situ (P less than 0.001).(ABSTRACT TRUNCATED AT 400 WORDS)

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041460687

Download citation: RISBibTeXText

PMID: 3825815


Related references

Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder. Hinyokika Kiyo. Acta Urologica Japonica 32(11): 1649-1662, 1986

Studies on multiple mucosal biopsy in patients with bladder cancer. 2. Evaluation on the relationship between the results of multiple mucosal biopsy and recurrence, and the clinical course of cases with carcinoma in situ and micro-invasion of carcinoma in situ. Hinyokika Kiyo. Acta Urologica Japonica 32(11): 1633-1647, 1986

Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining. Hinyokika Kiyo. Acta Urologica Japonica 32(11): 1617-1631, 1986

Avidin-biotin technique is more sensitive than lectin assay for detecting the Thomsen-Friedenreich antigen (T-antigen) in transitional cell carcinoma of the bladder. Journal of Surgical Oncology 27(4): 255-259, 1984

Prospective comparison of four sampling methods (cystocentesis, bladder mucosal swab, bladder mucosal biopsy, and urolith culture) to identify urinary tract infections in dogs with urolithiasis. Journal of the American Animal Hospital Association 34(5): 423-430, 1998

Thomsen friedenreich related antigen in non neoplastic ureter urothelium and transitional cell tumors of the urinary bladder an immunohistochemical study employing the monoclonal antibody 49h.8. Acta Pathologica Microbiologica et Immunologica Scandinavica Section A Pathology 95(2): 83-92, 1987

Historical and modern role of cystoscopy and bladder mucosal biopsy in detecting bladder cancer in a high-risk population. Journal of Occupational Medicine. 32(9): 834-837, 1990

The impact of prostatic mucosal involvement or stromal invasion of transitional cell carcinoma tcc on survival in patients undergoing cystoprostatectomy for bladder cancer. Journal of Urology 143(4 Suppl.): 289A, 1990

Flow cytometric evaluation of Thomsen-Friedenreich antigen on transitional cell cancer using monoclonal antibody. Urological Research 18(2): 107-111, 1990

Mucosal biopsies from patients with transitional cell cancer of the bladder. Turkish Journal of Pediatrics 26(1-4): 233-239, 1984

The sensitivity and clinical implications of periodical bladder biopsy following transurethral resection of superficial bladder transitional cell carcinoma. Hinyokika Kiyo. Acta Urologica Japonica 47(1): 1-4, 2001

Association of ABO (H) antigen negative transitional cell tumours with abnormal mucosal biopsies in superficial bladder cancer. Archivio Italiano di Urologia Nefrologia Andrologia 60(3): 295-299, 1988

Initial evaluation of the diagnostic performance of the new urinary bladder cancer antigen test as a tumor marker for transitional cell carcinoma of the bladder. Journal of Urology 161(4): 1110-1115, 1999

Evaluation of chromosome 8 and 11 aneuploidies in washings and biopsy materials of bladder transitional cell carcinoma. Cancer Genetics & Cytogenetics 142(1): 25-29, 2003

Management of mucosal prostatic urethral involvement in patients with superficial transitional cell carcinoma of the bladder. European Urology Suppl.s 1(1): 120, 2002